US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by PerkinElmer Inc.

News headline image
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer to Present at J.P. Morgan Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer to Present at 2022 Stifel Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer to Present at Upcoming Investor Conferences
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa
From PerkinElmer Inc.
Via Business Wire
News headline image
PerkinElmer’s Horizon Discovery CHOSOURCE™ Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions
From PerkinElmer Inc.
Via Business Wire